We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
(+16%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$115M |
| 2 |
Bausch Health
BHC
|
+$84M |
| 3 |
Brookdale Senior Living
BKD
|
+$72M |
| 4 |
Abbott
ABT
|
+$56.3M |
| 5 |
AET
Aetna Inc
AET
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$160M |
| 2 |
Perrigo
PRGO
|
+$122M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$115M |
| 4 |
Amgen
AMGN
|
+$82M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.19% |
| 2 | Miscellaneous | 8.84% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Consumer Staples | 5.73% |
| 5 | Utilities | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ameren
AEE
$28.5B
| $5.79M | 0.11% |
160,154
+2,632
| +2% | +$94.5K |
|
|
DF
177
DELISTED
Dean Foods Company
DF
| $5.75M | 0.11% |
334,287
-4,952
| -1% | -$90.1K |
|
178
Rigel Pharmaceuticals
RIGL
$829M
| $5.73M | 0.11% |
+201,088
| New | +$5.9M |
|
|
INVX
179
Innovex International
INVX
$2.09B
| $5.69M | 0.11% |
+51,750
| New | +$5.85M |
|
|
TSRO
180
DELISTED
TESARO, Inc.
TSRO
| $5.66M | 0.11% |
+200,255
| New | +$7.43M |
|
|
MRO
181
DELISTED
Marathon Oil Corporation
MRO
| $5.64M | 0.11% |
159,875
+131,270
| +459% | +$4.68M |
|
182
Yelp
YELP
$1.15B
| $5.56M | 0.11% |
80,639
+31,628
| +65% | +$2.09M |
|
183
KeyCorp
KEY
$23.2B
| $5.53M | 0.11% |
412,005
+104,029
| +34% | +$1.32M |
|
184
Standard BioTools
LAB
$271M
| $5.53M | 0.11% |
144,259
-224,698
| -61% | -$6.62M |
|
|
OPEN
185
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
| $5.5M | 0.11% |
69,302
+29,272
| +73% | +$2.24M |
|
186
Reliance Steel & Aluminium
RS
$20B
| $5.45M | 0.11% |
71,842
+67,345
| +1,498% | +$4.98M |
|
|
HOUS
187
DELISTED
Anywhere Real Estate
HOUS
| $5.44M | 0.11% |
109,984
+61,128
| +125% | +$2.76M |
|
188
Emerson Electric
EMR
$82B
| $5.43M | 0.11% |
77,380
+62,202
| +410% | +$4.15M |
|
|
OCR
189
DELISTED
OMNICARE INC
OCR
| $5.4M | 0.11% |
89,517
+58,939
| +193% | +$3.38M |
|
|
FOE
190
DELISTED
Ferro Corporation
FOE
| $5.32M | 0.1% |
415,000
+5,000
| +1% | +$60.7K |
|
191
Tandem Diabetes Care
TNDM
$1.13B
| $5.26M | 0.1% |
+20,422
| New | +$4.67M |
|
192
Meta Platforms (Facebook)
META
$1.71T
| $5.11M | 0.1% |
93,430
+84,930
| +999% | +$4.26M |
|
193
Toll Brothers
TOL
$12.4B
| $5.08M | 0.1% |
+137,347
| New | +$4.56M |
|
194
Achieve Life Sciences
ACHV
$753M
| $5.01M | 0.1% |
273
+70
| +34% | +$1.23M |
|
195
HF Sinclair
DINO
$20B
| $5M | 0.1% |
100,565
+64,408
| +178% | +$2.94M |
|
196
Mondelez International
MDLZ
$79.3B
| $4.98M | 0.1% |
140,950
-10,771
| -7% | -$358K |
|
|
RFMD
197
DELISTED
RF MICRO DEVICES INC
RFMD
| $4.97M | 0.1% |
963,438
-105,849
| -10% | -$568K |
|
|
SWY
198
DELISTED
SAFEWAY INC
SWY
| $4.9M | 0.1% |
+168,203
| New | +$5.05M |
|
199
Accuray
ARAY
$27.5M
| $4.79M | 0.09% |
+550,081
| New | +$4.27M |
|
200
Oshkosh
OSK
$8.84B
| $4.78M | 0.09% |
94,780
+78,932
| +498% | +$3.93M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management deployed $419M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 55% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.
- Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
- Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
- Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
- Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
- Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
- Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
- Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.
Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.